Health Trials

Migraine Aura

2

Review clinical trials related to Migraine Aura. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38

Pituitary Adenylate Cyclase Activating Polypeptide-38 (PACAP-38) is a key neuropeptide in migraine pathophysiology and treatment. This study investigates whether PACAP-38 administration can trigger aura in individuals with a diagnosis of migraine with aura.

Participants needed: 21
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Danish Headache CenterUpdated: Jan 15, 2026
Eligibility criteria

Age 18 to 65 years of age upon entry into screening [+3]

Any history of a primary or secondary headache disorder other than migraine with... [+8]

Read more
Status: Recruiting

Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide

Calcitonin gene-related peptide (CGRP) is a key neuropeptide in migraine pathophysiology and treatment. This study investigates whether CGRP administration can trigger aura in individuals with a diagnosis of migraine with aura.

Participants needed: 21
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Danish Headache CenterUpdated: Aug 6, 2025Locations: 1
Eligibility criteria

Age 18 to 65 years of age upon entry into screening [+3]

Any history of a primary or secondary headache disorder other than migraine with... [+10]

Read more